MAP2K7 and hepatocellular carcinoma: However, the up-regulation of p-MEK and p-ERK by sorafenib in HCCLM3 cells was different from previous studies because sorafenib could directly suppress the proliferation of HCC cells by inhibiting RAF kinase and blocking the RAF/MEK/ERK signal pathway [30].